GOLDLINE PHARMACEUTICAL LIMITE (GLPL)

BSE: ₹42.96
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Mar 2026
Revenue from Operations 17.31
YOY Revenue Growth % -
Other Income 0.00
Total Income 17.31
Total Expenses + 13.77
Cost of Materials Consumed 0.00
Employee Benefit Expense 3.74
Other Expenses 3.38
Operating Profit 3.53
OPM % 20.4%
Profit Before Tax + 3.53
Tax Expense 3.53
Tax % 100%
Profit After Tax 0.00
EPS (Basic) 3.43

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026
Revenue from Operations 31.20
YOY Revenue Growth % -
Other Income 0.00
Total Income 31.20
Total Expenses + 25.81
Employee Benefit Expense 7.07
Other Expenses 6.00
Operating Profit 5.38
OPM % 17.3%
Profit Before Exceptional 0.00
Exceptional Items 0.00
Profit Before Tax + 5.39
Tax Expense 5.39
Tax % 100%
Profit After Tax 0.00
EPS (Basic) 5.97

Balance Sheet

Particulars Mar 2026
ASSETS
Non-Current Assets + 2.82
Property, Plant & Equipment 2.65
Capital Work in Progress 0.00
Non-Current Investments 0.03
Goodwill 0.00
Other Intangible Assets 0.00
Current Assets + 26.05
Inventories 6.21
Trade Receivables 0.00
Cash and Cash Equivalents 0.59
Current Investments 0.00
LIABILITIES & EQUITY
Total Equity 0.00
Equity Share Capital 0.00
Other Equity 0.00
Non-Current Liabilities 2.51
Current Liabilities 12.11
Total Liabilities 0.00

Cash Flow Statement

Particulars Mar 2026
Cash from Operating Activities 2.81
Cash from Investing Activities -0.06
Cash from Financing Activities -3.40
Net Increase/Decrease in Cash -0.65